PubMed Health⌕ Search

Biomedical subjects

J G Sloman

Publications and source records attributed to J G Sloman.

At least 19 recordsLinked to original sources

Subendocardial myocardial infarction.

Sixty-one consecutive patients with acute subendocardial myocardial infarction (SEAMI) and 223 consecutive patients with transmural infarction (TMI) seen in a coronary care unit were followed for one year. All patients were less than 70 years of age. The patients with SEAMI had a higher frequency of previous infarction (34% vs 21%, p less than 0.025), less cardiac failure (44% vs 65%, p less than 0.005), and were more often free from arrhythmias (61% vs 31%, p less than 0.001) than patients with TMI. Hospital mortality was less in patients with SEAMI (0% vs 8%, p less than 0.05) but total mortality to one year was similar (15% vs 17%). Amongst patients with SEAMI, two died within two weeks of infarction but all other deaths occurred at least six weeks after infarction. Patients with SEAMI and a history of previous infarction had a higher one year mortality than patients without such a history (29% vs 7%, p less than 0.05). Coronary angiography with a view to coronary artery surgery should be considered in the former group.

Aged↗

The antiarrhythmic effect of intravenous disopyramide in an open study.

The antiarrhythmic effect of intravenous disopyramide phosphate was assessed in a multicentre open study of 141 patients admitted to coronary care units. Disopyramide was administered in a bolus dose of 2 mg/kg over 10 min with an optional second bolus of 1 mg/kg and infusion of 0.4 mg/kg hour. Atrial fibrillation was terminated in 57% of 56 patients, supraventricular tachycardia in 82% of 11 patients, ventricular tachycardia in 88% of 17 patients and premature ventricular contractions were controlled in 85% of 55 patients. Atrial flutter was terminated in only 2 of 17 patients (12%). Side effects occurred in 38% of the patients, the most frequent being those relating to anticholinergic properties of the drug (15%) or systemic hypotension (13%). Occasionally worsening of the arrhythmia (4%), QRS widening (3) or apparent hypertension (2%) were noted. It was concluded that intravenous disopyramide is an effective antiarrhythmic agent in the coronary care unit setting, but that side effects require close monitoring of dosage.

Adolescent↗

Recent concepts in the management of ischaemic cardiac syndromes.

Ischaemic heart disease is the most important cause of death in our society. Knowledge of the natural history of the various ischaemic syndromes leads to better management, with emphasis on prevention of cardiac necrosis rather than management of its sequelae. This article is from the Department of Cardiology, Royal Melbourne Hospital.

Adrenergic beta-Antagonists↗

The value of postcardiac infarction exercise stress testing: identification of a group at high risk.

We prospectively selected 154 patients who had survived acute myocardial infarction with electrical and/or mechanical complications to undergo an exercise stress test, four to six weeks after discharge from the Coronary Care Unit, Royal Melbourne Hospital. The patients exercised on a bicycle ergometer until they were unable to continue or had reached 70% of their predicted maximum heart rate for their age. Eighteen (11.7%) patients exhibited flat ST-depression of 1 mm or more on exercise. Six of these 18 patients later died (33.3%). Only seven (5.1%) of the 136 patients who exhibited no electrocardiographic change died during follow-up. We conclude that patients recording positive exercise stress test results after acute myocardial infarction, have a poorer prognosis and therefore should be considered for more intensive medical or surgical treatment.

Arrhythmias, Cardiac↗

Coronary artery graft surgery.

The last decade has seen significant technical advances in equipment for the procedure of, and the surgeon's operating skill in coronary artery by pass surgery. Such surgery is indicated when, despite medical treatment, angina is disabling; although evidence is increasing that patients whose pain is controlled should be considered for surgery. Late operations are more complex and expensive, and patients are exposed to a higher risk of sudden death in the intervening period. Delay may also allow the disease to progress to an inoperable state. Patients unlikely to benefit from medical treatment should be offered surgery as soon as their disease is identified by angiography. Intensive medical treatment, with its poorer control of symptoms, leads to an increasing dependence on the State of medicine, hospital facilities and sickness benefits. The reputedly expensive coronary artery bypass operation is cheaper both to the State and to the patient tha unoperated invalidism.

Angina Pectoris↗

The malfunctioning pacemaker system. Part I.

The success of an implanted cardiac pacemaker is dependent upon the establishment of a harmonious relationship between the artificial pacemaker and the human receiver. Failure of a pacemaker system may arise from an electronic or mechanical defect within the pacemaker, a physiologic problem, or from a poor relationship between the normal function of both. Such malfunctions may necessitate the repair, replacement, or repositioning of a pacemaker component or removal of a source of external interference. True pacemaker malfunctions must be clearly distinguished from pseudo-malfunctions, where there is no pacemaker system defect. These situations may, variously, require the repair of faulty testing equipment, reassessment of falsely interpreted test data, or treatment of the patient for an unrelated disorder. This paper outlines a system for investigating patients with suspected pacemaker malfunction. For simplicity, only malfunctions associated with the ventricular inhibited pacing system will be discussed.

Cardiac Pacing, Artificial↗

Effect of therapeutic dosage of lithium on the heart.

1 The cardiac effects of therapeutic levels of lithium were investigated in six healthy male volunteers. Subjects were studied: (1) before lithium ingestion, and (2) when steady-state plasma lithium levels were attained (at least 2 weeks after beginning daily lithium ingestion). 2 A 12-lead electrocardiogram (ECG) and high-speed high-fidelity ECG were used to record electrical activity of the heart. Fractional shortening of the left ventricle using echocardiography, and systolic time intervals (at rest and during exercise), were used as measures of myocardial performance. 3 In this group of healthy volunteers administration of lithium carbonate was associated with a reduction in T wave amplitude in standard electrocardiograms but no statistically significant impairment of myocardial performance.

Adolescent↗

The effect of long-term diphenylhydantoin therapy on glucose tolerance and insulin secretion: a controlled trial.

The influence of long-term administration of diphenylhydantoin (DPH) on glucose tolerance and insulin secretion was studied in a random controlled trial in non-epileptic patients receiving the drug for 2 years following recovery from myocardial infarction. While receiving DPH, insulin response to glucose was less than that in the control group, both in absolute terms and when related to the blood glucose level. Despite this, glucose tolerance did not differ from the control group. One month after cessation of DPH, the plasma insulin response had returned to the levels found in the control group, and glucose tolerance had improved to be significantly better than that found in the control group. Thus, the tendency of DPH to impair the insulin response to glucose has been confirmed in this controlled study. However, this does not result in significantly impaired glucose tolerance; it is suggested that the decreased insulin secretion is accompanied by improved insulin sensitivity.

Blood Glucose↗

An assessment of the clinical use of glyceryl trinitrate in a hospital outpatient population.

Despite the availability of information on the use of glyceryl trinitrate (GTN) in standard texts, in practice many patients fail to obtain maximum benefit from GTN. This study of an Outpatient population, documents the patients' knowledge of the use and precautions which should apply to GTN and records the ways in which these patients took the drug. Fifty patients who regularly took GTN (greater than 5 tablets per week) were asked a series of questions by the same interviewer. Forty-nine of the 50 patients took GTN for the relief of chest pain, but only 34 patients knew that the drug could be used to prevent chest pain. Although 48 patients kept their bulk supply of GTN in the original container, over 40% transferred some or all of the tablets to other containers and locations. Seventy per cent of patients knew that GTN tablets deteriorate with time. However, knowledge of the factors which influence the rate of deterioration was lacking. Less than half the patients knew that the prompt relief of pain or the local effects on the buccal mucosa could be used as simple tests of the activity of tablets. It is recommended that all physicians should take more time to explain to their patients how to use glyceryl trinitrate correctly.

Aged↗

Multiform ventricular tachycardia.

Electrophysiological studies were performed in three patients with chronic recurrent ventricular tachycardia (VT) associated with coronary artery disease. In each case the ventricular origin of the tachycardia was confirmed and induction of tachycardia by programmed stimulation suggested a re-entry mechanism. Multiple types of ventricular tachycardia were observed which differed in cycle length, QRS morphology, timing of local epicardial and endocardial ventricular electrograms and the use of the specialized conduction system for propagation. There was evidence of one or more re-entry circuits arising in or near previously infarcted areas, with features of cycle length alternation, change in exit points and variations in subsequent conduction through the myocardium and specialized conduction tissues. These findings suggest multiform VT can be due to a number of factors. A modified surgical approach is recommended for management of medically refractory VT when there is evidence of multiple types.

Adult↗

Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D.

A randomized controlled study was performed to investigate the effect of 2 years' monitored diphenylhydantoin (DPH) therapy on plasma 25-hydroxyvitamin D (25-OHD) in non-epileptic, non-institutionalized subjects. Mean +/- SEM plasma 25-OHD of 18 DPH-treated subjects at the end of 2 years' drug treatment was 59 +/- 8 nmol/l (23.6 +/- 3.2 ng/ml), which was not decreased compared to that of eighteen control subjects (54 +/- 8 nmol/l, 21.6 +/- 3.2 ng/ml). In addition, mean plasma 25-OHD had not changed 1 month after ceasing DPH. The treated group had a higher mean serum alkaline phosphatase (SAP) during DPH treatment, attributable to hepatic enzyme induction. It is concluded that therapeutic doses of DPH without other anticonvulsants do not have a clinically significant effect on plasma 25-OHD.

Adult↗